Skip to main content

Joseph Puglisi


PTC Therapeutics said this week that it has named Joseph Puglisi to its scientific advisory board.

Puglisi is currently an associate professor of structural biology and director of the Stanford Magnetic Resonance Laboratory at Stanford University School of Medicine, said PTC. His work focuses on the “dynamics of ribosome during translation, the molecular basis for antibiotic action against the ribosome, the mechanism of eukaryotic translation initiation and elongation, the structure and function of the hepatitis C virus internal ribosome, and RNA-protein interactions in the HIV virus,” the company added.

Puglisi received a PhD in biophysical chemistry from the University of California, Berkeley, according to PTC.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.